In the Uk , a patient needs to get his medication approved by the National Health Service and even though that hurdle has been overcome some time ago , it is still a struggle to get the correct cannabis based medication 
People with multiple sclerosis are struggling to access a cannabis-based drug which was approved for use on the Welsh NHS, doctors claim.Three years ago the oral spray Sativex was made available in Wales following approval from the All Wales Medical Strategy Group (AWMSG).It meant Wales became the first country in the UK to offer a cannabis-based drug for sufferers of the progressive condition.Sativex helps treat Welsh MS patients experiencing symptoms of muscle spasms and stiffness.But experts claim there is a “postcode lottery” in Wales when it comes to accessing the medication.
READ THE FULL STORY BELOW